Literature DB >> 23275130

Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines.

Shuji Mizumoto1, Duriya Fongmoon, Kazuyuki Sugahara.   

Abstract

Chondroitin sulfate (CS) and dermatan sulfate (DS) interact with various extracellular molecules such as growth factors, cytokines/chemokines, neurotrophic factors, morphogens, and viral proteins, thereby playing roles in a variety of biological processes including cell adhesion, proliferation, tissue morphogenesis, neurite outgrowth, infections, and inflammation/leukocyte trafficking. CS/DS are modified with sulfate groups at C-2 of uronic acid residues as well as C-4 and/or C-6 of N-acetyl-D-galactosamine residues, yielding enormous structural diversity, which enables the binding with numerous proteins. We have demonstrated that highly sulfated CS-E from squid cartilage, for example, interacts with heparin-binding proteins including midkine, pleiotrophin, and fibroblast growth factors expressed in brain with high affinity (Kd values in the nM range). Here, we analyzed the binding of CS and DS, which have a relatively low degree of sulfation and have been widely used as a nutraceutical and a drug for osteoarthritis etc., with a number of heparin-binding neurotrophic factors/cytokines using surface plasmon resonance (SPR) and structurally characterized the CS/DS chains. SPR showed that relatively low sulfated CS-A, DS, and CS-C also bound with significant affinity to midkine, pleiotrophin, hepatocyte growth factor, monokine-induced by interferon-γ, and stromal cell derived factor-1β, although the binding was less intense than that with highly sulfated CS-D and CS-E. These findings suggest that even low sulfated CS and/or DS chains may contain binding domains, which include fine sugar sequences with specific sulfation patterns, and that sugar sequences, conformations and electrostatic potential are more important than the simple degree of sulfation represented by disaccharide composition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23275130     DOI: 10.1007/s10719-012-9463-5

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  60 in total

1.  The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity.

Authors:  A E Proudfoot; S Fritchley; F Borlat; J P Shaw; F Vilbois; C Zwahlen; A Trkola; D Marchant; P R Clapham; T N Wells
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

2.  Structural and functional analysis of the RANTES-glycosaminoglycans interactions.

Authors:  L Martin; C Blanpain; P Garnier; V Wittamer; M Parmentier; C Vita
Journal:  Biochemistry       Date:  2001-05-29       Impact factor: 3.162

3.  Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides.

Authors:  A Kinoshita; K Sugahara
Journal:  Anal Biochem       Date:  1999-05-01       Impact factor: 3.365

Review 4.  Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate.

Authors:  Kazuyuki Sugahara; Tadahisa Mikami; Toru Uyama; Souhei Mizuguchi; Kazuya Nomura; Hiroshi Kitagawa
Journal:  Curr Opin Struct Biol       Date:  2003-10       Impact factor: 6.809

5.  Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity.

Authors:  Toru Uyama; Miho Ishida; Tomomi Izumikawa; Edward Trybala; Frank Tufaro; Tomas Bergström; Kazuyuki Sugahara; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2006-10-13       Impact factor: 5.157

Review 6.  Regulation of protein function by glycosaminoglycans--as exemplified by chemokines.

Authors:  T M Handel; Z Johnson; S E Crown; E K Lau; A E Proudfoot
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

Review 7.  CXCL12: a new player in coronary disease identified through human genetics.

Authors:  Samira S Farouk; Daniel J Rader; Muredach P Reilly; Nehal N Mehta
Journal:  Trends Cardiovasc Med       Date:  2010-08       Impact factor: 6.677

8.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.

Authors:  E Oberlin; A Amara; F Bachelerie; C Bessia; J L Virelizier; F Arenzana-Seisdedos; O Schwartz; J M Heard; I Clark-Lewis; D F Legler; M Loetscher; M Baggiolini; B Moser
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

9.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Authors:  Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

10.  Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA/1J mice.

Authors:  So Yean Cho; Joon-Soo Sim; Choon Sik Jeong; Seung Yeup Chang; Don Woong Choi; Toshihiko Toida; Yeong Shik Kim
Journal:  Biol Pharm Bull       Date:  2004-01       Impact factor: 2.233

View more
  31 in total

1.  Glioma Cell Invasion is Significantly Enhanced in Composite Hydrogel Matrices Composed of Chondroitin 4- and 4,6-Sulfated Glycosaminoglycans.

Authors:  Meghan T Logun; Nicole S Bisel; Emily A Tanasse; Wujun Zhao; Bhagya Gunasekera; Leidong Mao; Lohitash Karumbaiah
Journal:  J Mater Chem B       Date:  2016-08-26       Impact factor: 6.331

Review 2.  Pleiotrophin: Activity and mechanism.

Authors:  Xu Wang
Journal:  Adv Clin Chem       Date:  2020-03-12       Impact factor: 5.394

3.  Structural studies reveal an important role for the pleiotrophin C-terminus in mediating interactions with chondroitin sulfate.

Authors:  Eathen Ryan; Di Shen; Xu Wang
Journal:  FEBS J       Date:  2016-03-06       Impact factor: 5.542

4.  Surfen-mediated blockade of extratumoral chondroitin sulfate glycosaminoglycans inhibits glioblastoma invasion.

Authors:  Meghan T Logun; Kallie E Wynens; Gregory Simchick; Wujun Zhao; Leidong Mao; Qun Zhao; Subhas Mukherjee; Daniel J Brat; Lohitash Karumbaiah
Journal:  FASEB J       Date:  2019-08-09       Impact factor: 5.191

5.  Interactions of the Chemokine CCL5/RANTES with Medium-Sized Chondroitin Sulfate Ligands.

Authors:  Courtney Deshauer; Ashli M Morgan; Eathen O Ryan; Tracy M Handel; James H Prestegard; Xu Wang
Journal:  Structure       Date:  2015-05-14       Impact factor: 5.006

Review 6.  Glycosaminoglycans in Neurodegenerative Diseases.

Authors:  Weihua Jin; Fuming Zhang; Robert J Linhardt
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 7.  Chemistry and Function of Glycosaminoglycans in the Nervous System.

Authors:  Nancy B Schwartz; Miriam S Domowicz
Journal:  Adv Neurobiol       Date:  2023

Review 8.  Chondroitin sulfate/dermatan sulfate sulfatases from mammals and bacteria.

Authors:  Shumin Wang; Kazuyuki Sugahara; Fuchuan Li
Journal:  Glycoconj J       Date:  2016-08-15       Impact factor: 2.916

9.  The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.

Authors:  Douglas P Dyer; Catherina L Salanga; Brian F Volkman; Tetsuya Kawamura; Tracy M Handel
Journal:  Glycobiology       Date:  2015-11-17       Impact factor: 4.313

10.  ChGn-2 Plays a Cardioprotective Role in Heart Failure Caused by Acute Pressure Overload.

Authors:  Andreas Haryono; Koji Ikeda; Dhite Bayu Nugroho; Takehiro Ogata; Yumika Tsuji; Satoaki Matoba; Kensuke Moriwaki; Hiroshi Kitagawa; Michihiro Igarashi; Ken-Ichi Hirata; Noriaki Emoto
Journal:  J Am Heart Assoc       Date:  2022-03-24       Impact factor: 6.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.